|
Amnesia
|
0.510 |
Biomarker
|
disease |
BEFREE |
Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats.
|
30863075 |
2019 |
|
Amnesia
|
0.510 |
Biomarker
|
disease |
RGD |
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
|
17276409 |
2007 |
|
Amnesia
|
0.510 |
Biomarker
|
disease |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Hypertensive disease
|
0.500 |
Biomarker
|
group |
CTD_human |
Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.
|
9050021 |
1997 |
|
Hypertensive disease
|
0.500 |
Biomarker
|
group |
RGD |
Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.
|
9050021 |
1997 |
|
Memory impairment
|
0.320 |
Biomarker
|
phenotype |
BEFREE |
Histamine H3 Receptor Antagonist Prevents Memory Deficits and Synaptic Plasticity Disruption Following Isoflurane Exposure.
|
28168839 |
2017 |
|
Memory impairment
|
0.320 |
Biomarker
|
phenotype |
BEFREE |
The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats.
|
29075190 |
2017 |
|
Memory impairment
|
0.320 |
Biomarker
|
phenotype |
CTD_human |
Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats.
|
16488453 |
2006 |
|
Memory Disorders
|
0.300 |
Biomarker
|
disease |
CTD_human |
Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats.
|
16488453 |
2006 |
|
Age-Related Memory Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats.
|
16488453 |
2006 |
|
Memory Disorder, Semantic
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats.
|
16488453 |
2006 |
|
Memory Disorder, Spatial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats.
|
16488453 |
2006 |
|
Memory Loss
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats.
|
16488453 |
2006 |
|
Hysterical amnesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Temporary Amnesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Dissociative Amnesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Global Amnesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Tactile Amnesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Amnestic State
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.
|
11125734 |
1999 |
|
Obesity
|
0.230 |
Biomarker
|
disease |
BEFREE |
Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).
|
23591112 |
2013 |
|
Obesity
|
0.230 |
Biomarker
|
disease |
BEFREE |
Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
|
23591110 |
2013 |
|
Obesity
|
0.230 |
Biomarker
|
disease |
RGD |
The present study suggests that antagonistic targeting of the histamine H(3) receptor decreases food intake, body weight, and plasma TG levels and, thus, represents an interesting approach to treatment of obesity and associated hyperlipidemia.
|
17189541 |
2006 |
|
Obesity
|
0.230 |
Biomarker
|
disease |
BEFREE |
Histamine H(3) receptor antagonists are potential therapeutic agents for cognitive dysfunction, epilepsy, hypersomnia and obesity.
|
16316645 |
2006 |
|
Status Epilepticus
|
0.210 |
Biomarker
|
disease |
BEFREE |
The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in Rats.
|
31739417 |
2019 |
|
Status Epilepticus
|
0.210 |
Biomarker
|
disease |
RGD |
Transient changes in the limbic histaminergic system after systemic kainic acid-induced seizures.
|
16137576 |
2005 |